BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8236254)

  • 1. Decreased expression of cytochrome P450 mRNAs and related steroid hydroxylation activities in hepatic hyperplastic nodules in male F344 rats.
    Chen ZY; White CC; Eaton DL
    Toxicol Appl Pharmacol; 1993 Nov; 123(1):151-9. PubMed ID: 8236254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zonal differences in DNA synthesis activity and cytochrome P450 gene expression in livers of male F344 rats treated with five nongenotoxic carcinogens.
    Chen ZY; White CC; He CY; Liu YF; Eaton DL
    J Environ Pathol Toxicol Oncol; 1995; 14(2):83-99. PubMed ID: 9372837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of male-specific cytochrome P450s 2C11 and 3A2 in bile duct-ligated male rats: importance to reduced hepatic content of cytochrome P450 in cholestasis.
    Chen J; Murray M; Liddle C; Jiang XM; Farrell GC
    Hepatology; 1995 Aug; 22(2):580-7. PubMed ID: 7635428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
    Chang TK; Waxman DJ
    Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of cytochrome P450 mRNA during chemical-induced hepatocarcinogenesis and following partial hepatectomy.
    Habib SL; Srikanth NS; Scappaticci FA; Faletto MB; Maccubbin A; Farber E; Ghoshal AK; Gurtoo HL
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):139-48. PubMed ID: 8291055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate.
    Waxman DJ; Ram PA; Pampori NA; Shapiro BH
    Mol Pharmacol; 1995 Nov; 48(5):790-7. PubMed ID: 7476908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluconazole-induced hepatic cytochrome P450 gene expression and enzymatic activities in rats and mice.
    Sun G; Thai SF; Lambert GR; Wolf DC; Tully DB; Goetz AK; George MH; Grindstaff RD; Dix DJ; Nesnow S
    Toxicol Lett; 2006 Jun; 164(1):44-53. PubMed ID: 16406388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon gamma down-regulates cytochrome P450 3A genes in primary cultures of well-differentiated rat hepatocytes.
    Tapner M; Liddle C; Goodwin B; George J; Farrell GC
    Hepatology; 1996 Aug; 24(2):367-73. PubMed ID: 8690406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between growth stimulation by phenobarbital and expression of cytochromes P450 1A1, 1A2, 2B1/2 and 3A1 in hepatic hyperplastic nodules in male F344 rats.
    Chen ZY; Farin F; Omiecinski CJ; Eaton DL
    Carcinogenesis; 1992 Apr; 13(4):675-82. PubMed ID: 1349513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cell proliferation by ciprofibrate in glutathione S-transferase P1-1-positive rat hepatic hyperplastic nodules.
    Chen ZY; Liu YF; He CY; White CC; Eaton DL
    Cancer Res; 1994 May; 54(10):2622-9. PubMed ID: 7909493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective suppression of rat hepatic cytochrome P450 2C11 by chloramphenicol.
    Kraner JC; Morgan ET; Halpert JR
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1367-72. PubMed ID: 7932191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cytochrome P450 1A1 and 1A2 by hyperoxia.
    Okamoto T; Mitsuhashi M; Fujita I; Sindhu RK; Kikkawa Y
    Biochem Biophys Res Commun; 1993 Dec; 197(2):878-85. PubMed ID: 8267628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of rat hepatic CYP2B1/2B2 and 2E1 by pyridine: differential induction kinetics and molecular basis of expression.
    Kim H; Putt D; Reddy S; Hollenberg PF; Novak RF
    J Pharmacol Exp Ther; 1993 Nov; 267(2):927-36. PubMed ID: 8246169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of cytochrome(s) P450 2B1/2 by phenobarbital in hepatic hyperplastic nodules induced by aflatoxin B1 or diethylnitrosamine plus 2-acetylaminofluorene in male F344 rats.
    Chen ZY; Eaton DL
    Toxicol Appl Pharmacol; 1991 Oct; 111(1):132-44. PubMed ID: 1949030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of a dietary phytochemical 3,3'-diindolylmethane on the phenobarbital-induced hepatic CYP mRNA expression and CYP-catalyzed reactions in female rats.
    Parkin DR; Lu Y; Bliss RL; Malejka-Giganti D
    Food Chem Toxicol; 2008 Jul; 46(7):2451-8. PubMed ID: 18486294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between responsiveness to phenobarbital induction of CYP2B1/2 and 3A1 in rat hepatic hyperplastic nodules and their zonal origin.
    Chen ZY; Eaton DL
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):185-90. PubMed ID: 8013408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spurious observation of splenic cyp2b1 expression.
    Sharma MR; Periandythevar P; Shapiro BH
    Drug Metab Dispos; 2003 Sep; 31(9):1074-6. PubMed ID: 12920159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of phenobarbital-inducible cytochrome P450 2B1/2 mRNA by lovastatin and oxysterols in primary cultures of adult rat hepatocytes.
    Kocarek TA; Schuetz EG; Guzelian PS
    Toxicol Appl Pharmacol; 1993 Jun; 120(2):298-307. PubMed ID: 8511800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course for the modulation of hepatic cytochrome P450 after administration of ethylbenzene and its correlation with toluene metabolism.
    Yuan W; Sequeira DJ; Cawley GF; Eyer CS; Backes WL
    Arch Biochem Biophys; 1997 Mar; 339(1):55-63. PubMed ID: 9056233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P4502E1- and cytochrome P4502B1/2B2-catalyzed carbon tetrachloride metabolism: effects on signal transduction as demonstrated by altered immediate-early (c-Fos and c-Jun) gene expression and nuclear AP-1 and NF-kappa B transcription factor levels.
    Gruebele A; Zawaski K; Kaplan D; Novak RF
    Drug Metab Dispos; 1996 Jan; 24(1):15-22. PubMed ID: 8825185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.